Rezolute (RZLT) Amortization of Deferred Charges (2012 - 2019)
Rezolute (RZLT) posted Amortization of Deferred Charges of $80000.0 for Q4 2020, up 35.59% sequentially from $59000.0 in Q3 2020, and down 3.61% YoY from $83000.0 in Q1 2020.
Powered by 
Analysis
Rezolute (RZLT) Amortization of Deferred Charges (2012 - 2019) Analysis & Trends
Rezolute has reported Amortization of Deferred Charges for 6 years, with the latest figure at $80000.0 in Q4 2020.
- Quarterly Amortization of Deferred Charges fell 3.61% year-over-year to $80000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $3000.0 (down 99.51% YoY) and the FY2019 annual result came in at $2.1 million, changed N/A from the prior year.
- Amortization of Deferred Charges rose to $80000.0 in Q4 2020 per RZLT's latest filing, from $59000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $878000.0 in Q4 2018 and troughed at -$136000.0 in Q1 2020.
- A 3-year average of $274000.0 and a median of $81500.0 in 2019 frame the typical range for Amortization of Deferred Charges.
- The widest YoY moves for Amortization of Deferred Charges: up 11.32% in 2020, down 128.81% in 2020.
- Over 3 years, Amortization of Deferred Charges stood at $878000.0 in 2018, then sank by 90.55% to $83000.0 in 2019, then dropped by 3.61% to $80000.0 in 2020.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $80000.0, $59000.0, and -$136000.0 for Q4 2020, Q3 2020, and Q1 2020 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 472,000.00 |
| Dec 31, 2018 | 878,000.00 |
| Sep 30, 2018 | 703,000.00 |
| Mar 31, 2014 | 266,693.00 |
| Dec 31, 2013 | 74,136.00 |
| Sep 30, 2013 | 75,508.00 |
| Jun 30, 2013 | 90,585.00 |
| Mar 31, 2013 | 101,082.00 |
| Dec 31, 2012 | 42,643.00 |
| Sep 30, 2012 | 44,786.00 |
| Jun 30, 2012 | 59,021.00 |
| Mar 31, 2012 | 47,833.00 |